1 October 2015
PureTech Health plc
Notice of Option Grant to Person Discharging Managerial Responsibilities
PureTech Health plc discloses the following grant to Michael MacLean, its newly hired CFO & Executive Vice President, of an Option to purchase Ordinary Shares pursuant to its Performance Share Plan as detailed below:
Recipient |
Class of share |
Number of shares over which Option granted |
Exercise Price |
Date on which Option was granted |
Michael MacLean |
Ordinary Shares of one pence each |
159,344 |
125 pence per share |
29 September 2015 |
The Option will become exercisable as to 25% of the underlying shares (39,836 shares) on 17 September 2016 and as to the remaining shares in equal tranches of 19,918 shares on the last day of each six month period following 29 September 2016 through to the fourth anniversary of 17 September 2016.
This disclosure relates to notification of transactions in accordance with DTR 3.1.2R and is given in fulfillment of the obligation under DTR 3.1.4R.
-Ends-
For further information, please contact:
PureTech Health plc Julie DiCarlo, Senior Vice President, Communications and Investor Relations |
+1 617 456 0032 |